Yangzhong Liu

42PUBLICATIONS
42CO-AUTHORS
Predictive and prognostic markersMolecular targetsMining engineeringCancer therapy (excl. chemotherapy and radiation therapy)Medical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (42)

|Sep 08, 2026
A Ubiquinone-Reactive Pt(IV) Prodrug Perturbs Mitochondrial Metabolism for Selective Tumor Suppression.

|Feb 24, 2026
Tumor-Directed Disulfidptosis via Spatiotemporally Controlled Copper Bioorthogonal Activation.

Yichen Yin, Wenxin Yu, Zhengqi Shen

|Jan 06, 2026
Rosmarinic Acid Is an hCtr1 Inhibitor that Interferes with Copper Transport Activity.

Fei Chen, Sisi Wu, Jian Kuang

|Jun 08, 2024
Reactions of Cisplatin with Thioredoxin-1 Regulate Intracellular Redox Homeostasis.

Shenghu Wang, Siming Yuan, Hongze Hu

|Mar 16, 2024
Enhancing Tumor Immunotherapy by Multivalent Anti-PD-L1 Nanobody Assembled via Ferritin Nanocage.

Manman Liu, Duo Jin, Wenxin Yu

|Feb 16, 2024
A non-metal single atom nanozyme for cutting off the energy and reducing power of tumors.

Junjie Cheng, Li Li, Duo Jin

Pageof 7

Frequent Collaborators

9 joint publications

Junjie Cheng

6 joint publications

Guangming Huang

6 joint publications

Yang Zhu

3 joint publications

Kaiming Cao